BNGO
Bionano Genomics, Inc.
0.46
-
0.03
5.14%
1 x 0.46
2 x 0.60
bid
ask
2 @ 04:00 PM
0.48+0.01 (2.47%)
![](/assets/images/down.png)
![](/assets/images/up.png)
sentiment
0.46
day range
0.49
0.31
52 week range
3.85
Prev Close0.49
Open0.49
Low0.46
High0.49
Volume607.10K
Avg. Volume1.80M
Market Cap39.97M
Inst. Own11.76%
Beta2.33
Short Ratio2.14
Div & Yield0.00 /
EPS9.89
P/E0.05
1yr Target2.73
50day MA0.57
200day MA1.05
CNQ.TO
Canadian Natural Resources Limited
47.13
04:00 PM
-
1.65
3.38%
G.TO
Augusta Gold Corp.
0.67
03:35 PM
-
0.10
12.99%
AAA.AX
BetaShares Australian High Interest Cash ETF
50.12
02:10 AM
+
0.00
0.00%
ACC.NS
ACC Limited
2348.55
06:00 AM
+
7.25
0.31%
600690.SS
Haier Smart Home Co., Ltd.
25.31
03:00 AM
+
0.13
0.52%
0700.HK
Tencent Holdings Limited
372.80
04:08 AM
-
5.40
1.43%
1101.TW
TCC Group Holdings Co., Ltd.
31.75
01:30 AM
-
0.40
1.24%
20MICRONS.NS
20 Microns Limited
327.20
05:59 AM
+
12.00
3.81%
Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
News
...
Profile
...
Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA. The company also provides Saphyr and Bionano compute servers; and VIA software, which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; OGM-Dx HemeOne testing; OGM-Dx FSHD, a test for individuals suspected of having FSHD type 1; and OGM-Dx Postnatal Whole Genome SV and OGM-Dx Prenatal Whole Genome SV for comprehensive testing. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California.
Earning
...
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-08-07 | 2024-06 | 0 | -0.24 | N/A | N/A |
2024-05-08 | 2024-03 | 0 | -0.6 | N/A | N/A |
2024-05-08 | 2024-03 | 0 | N/A | N/A | N/A |
2024-03-05 | 2023-12 | 0 | -0.96 | N/A | N/A |
2024-03-05 | 2023-12 | 0 | N/A | N/A | N/A |
2023-11-08 | 2023-09 | -0.75 | -1.48 | -0.73 | -97.33% |
Upgrade / Downgrade
...
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-08-09 | BTIG | Upgrade | Buy | Buy |
Insider Holder
...
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2022-07-06 | BARKER DAVID L | Director | 58.36K | Conversion of Exercise of derivative security |
2024-06-02 | CHAUBEY ALKA PH.D. | Officer | 48.25K | Stock Award(Grant) |
2024-06-02 | DIXON JONATHAN V | General Counsel | 18.02K | Stock Award(Grant) |
2024-06-02 | HOLMLIN R ERIK | Chief Executive Officer | 122.32K | Stock Award(Grant) |
2024-06-02 | KAMA GULSEN | Chief Financial Officer | 16.00K | Stock Award(Grant) |
2022-08-14 | LINNEY YVONNE | Director | 0.00 | Sale |
Institution Ownership
...
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 1.45M | 885.53K | 4.11% |
2023-06-29 | Blackrock Inc. | 613.69K | 374.35K | 1.74% |
2023-06-29 | Qube Research & Technologies Ltd | 393.95K | 240.31K | 1.11% |
2023-06-29 | State Street Corporation | 383.77K | 234.10K | 1.09% |
2023-06-29 | Mitsubishi UFJ Kokusai Asset Management Co., Ltd | 358.95K | 218.96K | 1.02% |
2023-06-29 | Millennium Management Llc | 333.07K | 203.17K | 0.94% |
Fund Ownership
...
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 889.85K | 542.81K | 2.52% |
2023-06-29 | Vanguard Extended Market Index Fund | 406.54K | 247.99K | 1.15% |
2023-08-30 | SPDR (R) Ser Tr-SPDR� Kensho New Economies Composite ETF | 258.12K | 996.34K | 0.73% |
2023-05-30 | Fidelity Extended Market Index Fund | 152.01K | 105.18K | 0.43% |
2023-09-29 | Global X Fds-Global X Genomics & Biotechnology ETF | 136.15K | 412.53K | 0.39% |
2023-05-30 | Schwab Strategic Tr-Schwab U.S. Small Cap ETF | 125.49K | 86.83K | 0.36% |
Split
...
Split | Date |
---|---|
1 : 10 | 2023-08-07 |
This topic has been deleted. Only users with topic management privileges can see it.
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
I really hope that BNGO mgmt has got a good strategy planned out to leverage on recent purchase and talent acquisitions with potential new markets and partnerships due to them. There’s just ain’t news at all from marketing dept which incidentally is the reason for the high expenditures in the past quarters.
-
-
Many Still Looking Away From Bionano Genomics, Inc. (NASDAQ:BNGO)
news.google.com • -
Bionano to Present at the Canaccord Genuity 44th Annual Growth Conference
globenewswire.com • -
3 Sorry Healthcare Stocks to Sell in May While You Still Can
investorplace.com • -
Lab Instrument Industry Update - New Commercial Entrants
seekingalpha.com • -
The 3 Best Healthcare Stocks to Buy in May 2024
investorplace.com • -
Bionano Genomics, Inc. (BNGO) Q1 2024 Earnings Call Transcript
seekingalpha.com • -
3 Contrarian Investments to Make Now for Massive Upside Potential
investorplace.com • -
Bionano Genomics, Inc. (BNGO) Q4 2023 Earnings Call Transcript
seekingalpha.com •